Objectives To describe the clinical evolution and predictors of symptom persistence during 2
months' follow-up in adults with noncritical coronavirus disease 2019 (COVID-19). Methods …

We report the strategy leading to the first detection of variant of concern 202012/01 (VOC) in
France (21 December 2020). First, the spike (S) deletion H69–V70 (ΔH69/ΔV70), identified …

The impact of a third dose of COVID-19 vaccine on antibody responses is unclear in
immunocompromised patients. The objective of this retrospective study was to characterize antibody …

There is no reliable and simple diagnostic marker available to diagnose recent hepatitis C
virus (HCV) infection. It has been shown that the avidity of specific IgG antibody is low in …

Background. Prevalence and risk factors for isolated antibody to hepatitis B core antigen (anti-HBc)
and occult hepatitis B virus (HBV) infection are not well known in human …

The pretherapeutic presence of protease inhibitor (PI) resistance-associated variants (RAVs)
has not been shown to be predictive of triple-therapy outcomes in treatment-naive patients. …

Background In 2014–2015, 242 individuals aged 2–89 years were newly diagnosed with
human immunodeficiency virus type 1 (HIV-1) in Roka, a rural commune in Cambodia. A case-…

Objectives The aim of the present study was to evaluate the clinical performance of four
SARS-CoV-2 immunoassays and their contribution in routine care for the diagnosis of COVID-19…

Background/Objectives Guidelines for optimized HCV screening are urgently required in
Africa, especially for patients infected with HIV, who sometimes show false positive or false …

Viral hepatitis E is an endemic infection in developing countries. Emerging cases of
autochthonous hepatitis E have been observed in developed countries, especially in France. …